Resource Center

Explore our comprehensive library of clinical publications, abstracts, news, events, newsletters, marketing materials and press releases.
Discover how Pulsenmore is shaping the future of healthcare delivery

Filter By:

Search
resources-top-bg

The ESHRE, 40th Annual Meeting in Amsterdam 2024 is just around the corner, and we’ll be there! Looking forward to fascinating scientific talks, reconnecting with our valued partners and thrilled

The annual meeting of the Israeli Society for Ultrasound in OBGYN Dead Sea, Israel will take placew between 5-7 September at the ENJOY hotel, aat the Dead Sea in Israel.

Reliable folliculometry and endometrial measurements can be obtained based on patient self-use of PFCVD, utilizing safe remote management of ovarian stimulation, reducing costs, discomfort and travel time for patients.

Congratulations to Dr. Liat Mor Wolfson Hospital for her outstanding presentation at Wolfson Research Day! Liat showcased her team’s innovative work on reducing anxiety during pregnancy through bi-weekly virtual visits

The WCFM, World Congress of The Fetal Medicine Foundation Lisbon 2024 is just around the corner, and we’ll be there! Looking forward to fascinating scientific talks, reconnecting with our valued

We’re thrilled to announce that for the third consecutive year, Clalit Health Services has been honored with the prestigious People and IT Award for the successful implementation of the Pulsenmore

resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

Yes, the device is reliable and was tested, validated and approved for use in Europe, Australia, Brazil and Israel. Over 120,000 successful scans have been performed since the launch of the technology. These numbers demonstrate that women can confidently scan themselves, as the diagnoisis it self is being done by a trained clinical team. The remote clinical team can accurately identify parameters related to fetal vitality, such as fetal heartbeat, fetal movements, and amniotic fluid volume, based on these scans.

Ultrasound has always been the imaging modality of choice for prenatal care due to its’ high safety profile for both mother and fetus. No cellular radiation is used during the scan. The phone only serves as a power source and display screen for the ultrasound cradle.

Pulsenmore collects four types of data: Service logs: Application usage logs, such as performance logs and errors.Technical information about the smartphone: Smartphone capabilities, application version, language, etc. Clinical information: Ultrasound clips, scan ti• Interpreter Data: The identifiers of the clinicians that interpret the scans.me, scan measurements and last menstrual period (LMP).

The health care provider derermines the maximum amount of scans that can be performed by the user. The device is limited to upto 50 scans per preganany.

The Pulsenmore was designed to follow ALARA principles as follows:

The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinican’s discretion in the clinician guided mode, only clinican can modify the ultrasound parameters (i.e., depth, gain, frequesncy etc.), each scan is enabled only upon the approval of a medical professional.